Device Electrophysiology

Viewmate

Payments companies reported to CMS as associated with Viewmate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$56Kassociated payments (2023-2025)
701clinicians with associated payments
1company reporting

By year

2023 $16K
2024 $23K
2025 $17K

Payments reported as associated with Viewmate, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $37K
Cardiovascular Disease $4,371
Pain Medicine (Physical Medicine & Rehabilitation) $2,750
Interventional Cardiology $1,613
Family $1,535
Internal Medicine $1,392

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Viewmate

These are the largest totals companies reported as associated with Viewmate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Hany Demo Chicago, IL Clinical Cardiac Electrophysiology $6,289.63
Mansour Razminia Palos Heights, IL Clinical Cardiac Electrophysiology $3,844.94
Jonathan Silverman Dayton, OH Pain Medicine (Physical Medicine & Rehabilitation) $2,750.00
Jonathan Hsu San Diego, CA Clinical Cardiac Electrophysiology $2,261.14
Frederick Han San Diego, CA Clinical Cardiac Electrophysiology $2,208.13
Amish Dave Houston, TX Clinical Cardiac Electrophysiology $1,100.00
Nelson Prager Aurora, CO Cardiovascular Disease $787.33
Miguel Valderrabano Houston, TX Clinical Cardiac Electrophysiology $550.00
Craig Raphael East Norriton, PA Clinical Cardiac Electrophysiology $533.37
Danesh Modi East Norriton, PA Clinical Cardiac Electrophysiology $516.85

Prescribed Viewmate?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.